News
HCS Pharma awarded by Réseau Entreprendre Bretagne
Yesterday, we were invited by “Réseau Entreprise” for the laureates meeting.
Yesterday, we were invited by “Réseau Entreprise” for the laureates meeting.
It will be the 10th Anniversary of ELRIG Drug Discovery event this year. We will be very happy to be in Liverpool in the innovation zone.
Cell biology is part of the R&D activity in dermocosmetology. At HCS Pharma, we are developing dermocosmetology assay using our automation platform and high content analysis software.
EU Announces That by 2020, all scientific articles should be in open acces !
Your children came back to school ? It is the same for Meryl Roudaut who also just begin his PhD training
Emergence of 3D cell culture in cell biology represents a new area of cellular culture technology. Here at HCS Pharma, we are developing innovative 3D cells models for high content analysis.
Last month, an ambitious plan was presented in France. The goal is to place genome sequencing at the heart of clinical practice in next 10 years.
Julian BURSZTYKA participated to the 7th Cosm’ing event, on cosmetic ingredients & biotechnology
The comet assay is a sensitive, well established technique for quantifying DNA damage in eukaryotic cells.
HCS Pharma is proud to be a part of the CHOPIN Project (CHolesterol Personalized INnovation). Selected as one of the ten most innovative health research programs by the ANR (French Research Agency), the project will receive more than €8 million euros through the second wave of the “Investissements d’Avenir” (i.e. “Investing for the future” ) program of the French government.
We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in cellular biology and high content analysis.
We are happy to announce that Brittany region continue to help us (article in french) and co-funds one of our R&D projects in collaboration with Dr Anne Corlu, head of team 2 and Dr Bernard Fromenty, head of team 3 of UMR991 directed by Dr Bruno Clément in Rennes.
If you are in Cosm’ing meeting, don’t hesitate to go and discuss with Julian BURSZTYKA, our COO
Come at Cosm’ing in Saint-Malo and meet Julian Bursztka, COO of HCS Pharma. Discover all the advantages of using the High Content Screening technology to improve your active ingredients.
A brand new article shows the importance of outsourcing Drug Discovery and so on the growing potential of this market.
Expert opinion on the potential of High Content Screening
We were pleased to talk at e-health day organised in Paris by L’Usine Digital. Our intervention was focused on the importance of public/private collaboration for today innovation in biotechnology.
During ELRIGfr event in Rennes, We had the opportunity to present our work on genotoxicity assay (comet assay on TK6 & gH2AX on keratinocytes and HepG2) in collaboration with the team of in vitro of Galderma R&D. It is really exciting to work with them since they are really experts Read more…
Biosynthetic skeleton for ECM development.
140 people attented the previous ELRIGfr event in Rennes, co-organized by ELRIGfr and HCS Pharma
HCS Pharma will be present at the stressOX event, organised by Adebiotech at Biocitech
Interest of synthetic culture mediums for cell cultures and production…
Let’s discover how High Content Screening can boost your research (An example with an early toxicity assay)